Skip to content

RVMD

Revolution Medicines, Inc.

Key figures

MetricLatest
Revenue$02025
Gross profit$197MQ3 2026
Operating income−$1.7B
Net income−$1.9B
EPS−$9.13
Free cash flow−$1.4B